Intermittent vs. Continuous Blood Pressure Devices: Key Validation Differences

Blood pressure technologies now range from traditional cuff-based monitors to advanced systems that estimate pressure frequently or continuously. While both aim to report systolic and diastolic blood pressure, intermittent and continuous devices are validated differently because their outputs, clinical use cases, and reference pairing needs are fundamentally different. 

Understanding the validation pathway early helps sponsors select the correct reference method, build the right protocol, and generate evidence that matches intended use and performance claims.  

What is an Intermittent Blood Pressure Device? 

Intermittent blood pressure devices produce discrete readings, typically a single systolic and diastolic blood pressure value at a defined time point. Examples include: 

• Oscillometric arm cuffs 

• Wrist cuff systems 

• Spot-check wearable technologies

Validation studies for these systems typically compare individual device readings against dual auscultatory reference measurements collected by trained observers. For cuff-based intermittent devices, this pathway is commonly aligned with ISO 81060-2 methodologies. 

What is a Continuous Blood Pressure Device? 

Continuous blood pressure systems generate repeated, frequent, or beat-to-beat measurements over time. Examples include: 

• Finger cuff systems 

• Continuous non-invasive blood pressure monitors 

• Cuffless physiological monitoring devices 

  
  

These technologies often rely on advanced algorithms, waveform analysis, or multi-sensor integration. For continuous non-invasive blood pressure systems, ISO 81060-3 requires invasive arterial blood pressure monitoring as the reference method, providing beat-to-beat arterial pressure and waveform data for comparison. 

Study Design Differences: What Sponsors Should Expect 

Intermittent studies are built around measurement sequences. Key design elements include: 

• Prespecified participant distributions across blood pressure ranges 

• Standardized posture, rest periods, and cuff placement 

• Paired reference and device measurements collected in a defined sequence 

• Sequential or simultaneous measurement procedures, depending on study design 

Continuous studies are built around time alignment. Key design elements include: 

• Continuous data capture from the device under test and arterial line reference 

• Time synchronization procedures to ensure correct pairing at the same time points 

• Signal quality review and artifact handling 

  
  

The goal is the same for both pathways: to ensure device and reference values are comparable, reproducible, and suitable for accuracy analysis. The difference is how those comparisons are collected and paired. 

Released Standards: Which Pathway Applies? 

A practical way to think about standards selection is to map the standard to the device output type: 

• ISO 81060-2: intermittent automated cuff-based devices 

• ISO 81060-3: continuous non-invasive blood pressure systems requiring invasive arterial reference comparison 

• Cuffless intermittent devices: may require cuffless-specific validation strategies depending on output type, calibration approach, and intended use, with IEEE 1708 and the upcoming ISO 81060-7 

  
  

Selecting the correct pathway early helps ensure that the reference method, participant population, and statistical analysis plan are appropriate for the device technology. 

Cuffless Technology Considerations 

Cuffless devices may be intermittent or continuous depending on how they generate and report blood pressure values. Many also require calibration or initialization, which should be clearly defined in the validation protocol. Validation studies for cuffless technologies may need to assess: 

• Extended monitoring sessions 

• Calibration frequency 

• Accuracy drift over time 

• Blood pressure changes 

  
  

Conclusion 

Intermittent and continuous devices need to be validated for the estimation of blood pressure, but their validation approaches differ in meaningful ways. Intermittent validation is built around standardized measurement sequences and auscultatory reference comparisons, while continuous validation depends on invasive arterial reference measurements. 

For sponsors, the most effective validation programs start by matching device output type to the correct reference method and standard pathway. When that alignment is established early, protocols are clearer, datasets are easier to interpret, and performance claims map more cleanly to regulatory review. 

Call to Action 

Parameters Research Laboratory supports protocol development, reference method selection, and regulator-ready execution across intermittent and continuous blood pressure validation pathways. Ready to connect? Contact us today!